Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

MADISON, NJ US

1. 20110034526 Benzimidazole Compounds - This invention relates generally to benzimidazole-based modulators of Liver X receptors having formula and related methods: 02-10-2011
2. 20110033451 INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR 02-10-2011
3. 20110031206 Fluid Container - comprises a body a neck and a mouth The neck is deformable from a first stable condition to a second stable condition 02-10-2011
4. 20110028455 Indole-substituted 3-cyanopyridines As Kinase Inhibitors 02-03-2011
5. 20110027329 Single-use, Disposable Strip For Application Of Topical Compositions 02-03-2011
6. 20110027316 BLUETONGUE VIRUS VACCINE AND IMMUNOGENIC COMPOSITIONS, METHODS OF USE AND METHODS OF PRODUCING SAME 02-03-2011
7. 20110027292 Protein Formulations with Reduced Viscosity and Uses Thereof 02-03-2011
8. 20110020382 Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics 01-27-2011
9. 20110020348 PHARMACEUTICAL COMPOSITIONS AND METHODS USING SECRETED FRIZZLED RELATED PROTEIN 01-27-2011
10. 20110014624 Methods For Identifying Cells Suitable For Large-Scale Production of Recombinant Proteins 01-20-2011
11. 20100331333 Imidazo [1,2-B] Pyridazine Compounds - This invention relates generally to imidazo[1 2-b]pyridazine-based modulators of Liver X receptors having formula 12-30-2010
12. 20100324073 Pyrazolo [1,5-A] Pyrimidine Compounds - This invention relates generally to pyrazolo[1 5-a]pyrimidine-based modulators of Liver X receptors having 12-23-2010
13. 20100323005 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen 12-23-2010
14. 20100316666 Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition 12-16-2010
15. 20100311839 Burst Drug Release Compositions - solid dose composition comprising at least one pharmaceutically active ingredient and at least one controlled release 12-09-2010
16. 20100293118 METHODS AND SYSTEMS FOR PREDICTING PROTEIN-LIGAND COUPLING SPECIFICITIES 11-18-2010
17. 20100291240 Method to Stabilize a Dietary Supplement to Facilitate Joint Health in Humans 11-18-2010
18. 20100286071 Finger-1 Peptide Analogs of the TGF-Beta Superfamily 11-11-2010
19. 20100273816 Quinazoline Compounds - Disclosed are quinazoline-based modulators of Liver X receptors and related methods 10-28-2010
20. 20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5) 10-28-2010
21. 20100273238 Cellular Permissivity Factor for Viruses and Uses Thereof 10-28-2010
22. 20100267697 ION CHANNEL MODULATORS - The present teachings provide compounds of Formula STR00001 and pharmaceutically acceptable salts, hydrates, and esters 10-21-2010
23. 20100233204 Immunogenic Compositions and Methods for Treating and Preventing Animal Infections 09-16-2010
24. 20100233117 Adjuvant combination formulations - The use of 3-O-deacylated monophosphoryl lipid A or monophosphoryl lipid A and derivatives and analogs thereof 09-16-2010
25. 20100227859 TRICYCLIC COMPOUNDS AS MATRIX METALLOPROTEINASE INHIBITORS 09-09-2010
26. 20100221288 NOVEL STREPTOCOCCUS PNEUMONIAE OPEN READING FRAMES ENCODING POLYPEPTIDE ANTIGENS AND USES THEREOF 09-02-2010
27. 20100216886 POLYMORPHS OF N2-(1,1'-BIPHENYL-4-YLCARBONYL)-N1-[2-(4-FLUOROPHENYL)-1,1-DIMETHYLETHYL]- -L-ALPHA-GLUTAMINE 08-26-2010
28. 20100204245 Amino-pyridines As Inhibitors Of Beta-secretase 08-12-2010
29. 20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity 08-05-2010
30. 20100184786 Polar Quinazolines - Disclosed are polar quinazoline-based modulators of Liver X receptors and related methods 07-22-2010
31. 20100168194 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase 07-01-2010
32. 20100168106 Amino-5-(5-membered)heteroarylimidazolone Compounds And The Use Thereof For Beta-secretase Modulation 07-01-2010
33. 20100168091 Imidazole Amines As Inhibitors Of Beta-secretase 07-01-2010
34. 20100160622 METHOD FOR CONTROLLING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE MOLECULAR WEIGHT USING CARBON DIOXIDE 06-24-2010
35. 20100158953 METHOD FOR CONTROLLING STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A POLYSACCHARIDE MOLECULAR WEIGHT 06-24-2010
36. 20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases 06-24-2010
37. 20100151060 BOTANICAL BUTTER STICK LIP BALM - stick lip balm with efficacious amounts of natural moisturizer and organoleptic/sensory attributes of lip feel 06-17-2010
38. 20100143349 HUMANIZED ANTI-RAGE ANTIBODY - Compositions comprising antigen binding polypeptides that bind specifically to Receptor For Advanced Glycation 06-10-2010
39. 20100137363 Substituted Indoles And Methods Of Their Use 06-03-2010
40. 20100132059 TEMPERATURE-INDUCED POLYNUCLEOTIDES AND USES THEREFOR 05-27-2010
41. 20100124764 SINGLE CHAIN ANTIBODY LIBRARY DESIGN - The invention provides polynucleotide vectors and linkers and methods for designing and making single chain 05-20-2010
42. 20100120782 ENDOPARASITICIDAL GEL COMPOSITION - homogenous clear veterinary gel composition which has a broad spectrum of efficacy against endoparasites over a 05-13-2010
43. 20100120779 1-(ARYLSULFONYL)-4-(PIPERAZIN-1-YL)-1H-BENZIMIDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 05-13-2010
44. 20100120778 QUINOXALINE-BASED LXR MODULATORS - Disclosed are quinoxaline-based modulators of Liver X receptors and related methods 05-13-2010
45. 20100120634 COMPATIBLE DISPLAY VECTOR SYSTEMS - polynucleotide vector system used during polypeptide display that can be used to facilitate transfer of pools of 05-13-2010
46. 20100119534 MULTICOMPONENT IMMUNOGENIC COMPOSITION FOR THE PREVENTION OF BETA-HEMOLYTIC STREPTOCOCCAL (BHS) DISEASE 05-13-2010
47. 20100119471 MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE 05-13-2010
48. 20100113751 PURIFICATION OF ACIDIC PROTEINS USING CERAMIC HYDROXYAPATITE CHROMATOGRAPHY 05-06-2010
49. 20100113474 Antineoplastic Combinations of 4-Anilino-3-Cyanoquinolines and Capecitabine 05-06-2010
50. 20100113443 LIQUID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS 05-06-2010
51. 20100113304 COMPATIBLE DISPLAY VECTOR SYSTEMS - polynucleotide vector system used during polypeptide display that can be used to facilitate transfer of pools of 05-06-2010
52. 20100095900 DEVICE AND METHOD FOR CONTROLLING INSECTS 04-22-2010
53. 20100093725 SEMI-SOLID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS 04-15-2010
54. 20100087497 Benzimidazole Anthelmintic Compositions - veterinary anthelmintic composition that includes: at least 10% w/v of a benzimidazole anthlemintic 04-08-2010
55. 20100081682 39-Desmethoxy Derivatives of Rapamycin - 39-desmethoxyrapamycin derivatives and their uses thereof 04-01-2010
56. 20100069385 LIQUID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS 03-18-2010
57. 20100069340 PHARMACEUTICAL COMPOSITIONS OF AN SRC KINASE INHIBITOR AND AN AROMATASE INHIBITOR 03-18-2010
58. 20100068204 4-ARYLOXYQUINOLIN-2(1H)-ONES AS MTOR KINASE AND PI3 KINASE INHIBITORS, FOR USE AS ANTI-CANCER AGENTS 03-18-2010
59. 20100063023 Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors 03-11-2010
60. 20100062448 PROTEIN KINASE C ZETA AS A DRUG TARGET FOR ARTHRITIS AND OTHER INFLAMMATORY DISEASES 03-11-2010
61. 20100062018 MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE 03-11-2010
62. 20100061994 MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF 03-11-2010
63. 20100061982 3-SUBSTITUTED-1H-INDOLE, 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 03-11-2010
64. 20100056520 FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS 03-04-2010
65. 20100055185 COMPOSITION AND METHOD FOR TREATING HEMORRHOIDS AND/OR ANORECTAL DISORDERS 03-04-2010
66. 20100048123 SYSTEM AND METHOD FOR ENERGY EFFICIENT AIR COOLING, EXCHANGE AND CIRCULATION 02-25-2010
67. 20100047279 IMMUNOLOGICAL COMPOSITION - s comprising sulpholipo-cyclodextrin and saponin or Quil A 02-25-2010
68. 20100041692 PYRROLO[4,3,2-DE]QUINOLIN-8-AMINE COMPOUNDS AND METHODS OF THEIR PREPARATION AND USE 02-18-2010
69. 20100036123 PROCESS FOR THE PREPARATION OF 2,4-DICHLORO-7H-PYRROLO[2,3H]QUINAZOLINE 02-11-2010
70. 20100035957 Methods for the Use of Inhibitors of Cytosolic Phospholipase A2 02-11-2010
71. 20100035845 TIGECYCLINE FORMULATIONS - The invention is directed to a frozen pharmaceutical formulation suitable for administration to a subject parenterally 02-11-2010
72. 20100029677 4-ANILINO-3-QUINOLINECARBONITRILES FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) 02-04-2010
73. 20100029657 Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof 02-04-2010
74. 20100029648 11-Beta HSD1 Inhibitors - This invention relates to inhibiting 11 02-04-2010
75. 20100029645 Inhibitors of Cytosolic Phospholipase A2 02-04-2010
76. 20100029641 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE 02-04-2010
77. 20100029500 OLIGONUCLEOTIDE ARRAYS TO MONITOR GENE EXPRESSION AND METHODS FOR MAKING AND USING SAME 02-04-2010
78. 20100028952 FERMENTATION AND PURIFICATION OF ACTINOMADURA CHROMOPROTEIN AND RELATED SPECIES 02-04-2010
79. 20100022766 BIOSYNTHETIC GENE CLUSTER FOR THE PRODUCTION OF A COMPLEX POLYKETIDE 01-28-2010
80. 20100022593 Process for Producing Anticancer Agent LL-D45042 01-28-2010
81. 20100022536 Inhibitors of Cytosolic Phospholipase A2 01-28-2010
82. 20100016609 METHODS FOR THE PREPARATION OF AZOLE COMPOUNDS 01-21-2010
83. 20100015191 DEVICE AND METHOD FOR CONTROLLING INSECTS 01-21-2010
84. 20100015141 4-PHENOXY-6-ARYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE AND N-ARYL-6-ARYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 01-21-2010
85. 20100010012 GLUTAMATE AGGRECANASE INHIBITORS - modulators of metalloproteinase activity 01-14-2010
86. 20100003250 (2-ARYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)MORPHOLINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 01-07-2010
87. 20090326075 ENANTIOMERS OF O-DESMETHYL VENLAFAXINE - This invention provides pharmaceutically active enantiomers of the venlafaxine metabolite O-Desmethyl 12-31-2009
88. 20090326021 THIAZOLO NAPHTHYL ACIDS - thiazolo-naphthyl acids of the formula STR00001 and methods of using them to modulate PAI-1 expression and to treat PAI-1 12-31-2009
89. 20090325964 Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression 12-31-2009
90. 20090325951 THIENYL-AND FURANYL-ISOQUINOLINONES AND METHODS FOR USING THEM 12-31-2009
91. 20090325877 Combination Product of Receptor Tyrosine Kinase Inhibitor and Fatty Acid Synthase Inhibitor for Treating Cancer 12-31-2009
92. 20090325176 Gene Expression Profiles Associated with Asthma Exacerbation Attacks 12-31-2009
93. 20090325175 METHODs OF DETECTION AND QUANTIFICATION OF HOST CELL DNA CONTAMINATION OF PURIFIED PROTEINS 12-31-2009
94. 20090324586 LYOPHILIZATION CYCLE ROBUSTNESS STRATEGY 12-31-2009
95. 20090318470 1-SUBSTITUTED-3-(NAPHTHALEN-1-YLSULFONYL)-5-(PIPERAZIN-1-YL)-1H-INDAZOLE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 12-24-2009
96. 20090318442 THIAZOLYL-AND OXAZOLYL-ISOQUINOLINONES AND METHODS FOR USING THEM 12-24-2009
97. 20090318359 COMPOSITIONS AND METHODS OF USE OF ORF1358 FROM BETA-HEMOLYTIC STREPTOCOCCAL STRAINS 12-24-2009
98. 20090318358 COMPOSITIONS AND METHODS OF USE OF ORF 554 FROM BETA HEMOLYTIC STREPTOCOCCAL STRAINS 12-24-2009
99. 20090312530 Processes for the convergent synthesis of calicheamicin derivatives 12-17-2009
100. 20090312360 Antineoplastic Combinations Containing HKI-272 and Vinorelbine 12-17-2009
101. 20090311723 FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING 12-17-2009
102. 20090311271 Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1) 12-17-2009
103. 20090311217 3-SUBSTITUTED-1H-INDOLE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 12-17-2009
104. 20090304692 TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS 12-10-2009
105. 20090298820 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 12-03-2009
106. 20090291971 HETEROARYL ETHERS AND PROCESSES FOR THEIR PREPARATION 11-26-2009
107. 20090291079 TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS 11-26-2009
108. 20090287280 Portable moist heat system - portable moist heat delivery system comprising a water vapor generating portion comprising a water vapor source and a heat 11-19-2009
109. 20090270447 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof 10-29-2009
110. 20090270363 2-Aryl- and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof 10-29-2009
111. 20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors 10-22-2009
112. 20090263817 METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE AND COMPOSITIONS THEREOF 10-22-2009
113. 20090253732 Production Of Polyketides And Other Natural Products 10-08-2009
114. 20090253716 AMINO-IMIDAZOLONES FOR THE INHIBITION OF BETA-SECRETASE 10-08-2009
115. 20090253711 HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 10-08-2009
116. 20090246868 Serum-free vero cell banking process - provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine 10-01-2009
117. 20090239863 1-ARYL-OR 1- ALKYLSULFONYLBENZAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 09-24-2009
118. 20090239855 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders 09-24-2009
119. 20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) 09-24-2009
120. 20090220619 NUTRITIONAL FORMULATION - nutritional supplements that provide an adult with essential vitamins and minerals that may be lacking in the adult's diet and 09-03-2009
121. 20090214513 MAMMALIAN EXPRESSION SYSTEMS - The present invention features mammalian expression systems with improved production yields and method of using these 08-27-2009
122. 20090209572 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders 08-20-2009
123. 20090209527 Methods for Using Rapamycin Analogues in the Treatment of Neurological Disorders 08-20-2009
124. 20090209452 SUBSTANTIALLY PURE GLYCOPEPTIDE ANTIBIOTICS AC-98-1; AC-98-2; AC-98-3; AC-98-4 AND AC-98-5 08-20-2009
125. 20090203682 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological Disorders 08-13-2009
126. 20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease 08-13-2009
127. 20090192176 1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-30-2009
128. 20090192147 [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-30-2009
129. 20090186026 EPHRIN AND EPH RECEPTOR AGONISTS FOR MODULATION OF BONE FORMATION AND RESORPTION 07-23-2009
130. 20090181963 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES 07-16-2009
131. 20090176969 CLONING GENES FROM STREPTOMYCES CYANEOGRISEUS SUBSP. NONCYANOGENUS FOR BIOSYNTHESIS OF ANTIBIOTICS AND METHODS OF USE 07-09-2009
132. 20090176884 PHARMACEUTICAL SUSPENSION COMPOSITION - aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase 07-09-2009
133. 20090176827 MALEATE SALTS OF (E)-N--4-(DIMETHYLAMINO)-2-BUTENAMIDE AND CRYSTALLINE FORMS THEREOF 07-09-2009
134. 20090176819 39-Desmethoxy-39-Methyl Derivatives of Rapamycin 07-09-2009
135. 20090175906 Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof 07-09-2009
136. 20090175900 METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS 07-09-2009
137. 20090169584 Treatment of sleep disturbances - new composition for treating pain-associated sleep disturbances 07-02-2009
138. 20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus 06-25-2009
139. 20090162321 METHODS FOR PACKAGING PROPAGATION-DEFECTIVE VESICULAR STOMATITIS VIRUS VECTORS USING A STABLE CELL LINE THAT EXPRESSES G PROTEIN 06-25-2009
140. 20090156826 METHODS FOR THE PREPARATION OF HYDROXY-SUBSTITUTED ARYL SULFAMIDE COMPOUNDS 06-18-2009
141. 20090156537 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES 06-18-2009
142. 20090155784 ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION 06-18-2009
143. 20090155353 MICROEMULSIONS FOR PHARMACEUTICAL COMPOSITIONS 06-18-2009
144. 20090149458 PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORS 06-11-2009
145. 20090148436 ANTIBODY TO GDF8 AND USES THEREOF - The disclosure provides novel molecules related to growth and differentiation factor-8 in particular epitopes 06-11-2009
146. 20090142806 INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR 06-04-2009
147. 20090137516 COMPOSITIONS AND METHODS OF TREATING DYSLIPIDEMIA 05-28-2009
148. 20090124002 ALPHA-1D CALCIUM CHANNEL EXPRESSED IN ATRIUM 05-14-2009
149. 20090118276 THIENOPYRIMIDINES, THIENOPYRIDINES, AND PYRROLOPYRIMIDINES AS B-RAF INHIBITORS 05-07-2009
150. 20090117152 Mycoplasma Hyopneumoniae Avirulent Adjuvanted Live Vaccine 05-07-2009
151. 20090105461 Calicheamicin conjugates - Anti-Lewis Y antibodies are described 04-23-2009
152. 20090105303 SULFONYL-3-HETEROCYCLYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 04-23-2009
153. 20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide 04-23-2009
154. 20090099376 TIGECYCLINE AND METHODS OF PREPARING INTERMEDIATES 04-16-2009
155. 20090098577 METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE CASPASE 9 ACTIVITY VIA USE OF A KOSMOTROPIC SALT 04-16-2009
156. 20090098132 COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS 04-16-2009
157. 20090098086 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS 04-16-2009
158. 20090097026 COLOR MEASUREMENTS OF RECONSTITUTED TIGECYCLINE AND DEGRADANT THEREOF 04-16-2009
159. 20090093498 AMINO-5,5-DIPHENYLIMIDAZOLONE DERIVATIVES FOR THE INHIBITION OF BETA-SECRETASE 04-09-2009
160. 20090092635 HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN 04-09-2009
161. 20090088448 Rapamycin Derivatives and the Uses Thereof in the Treatment of Neurological Disorders 04-02-2009
162. 20090087431 METHODS OF TREATING BONE DISORDERS WITH MODULATORS OF AXL 04-02-2009
163. 20090082354 PYRAZOLO[5, 1-C] [1,2,4] TRIAZINES, METHODS FOR PREPARATION AND USE THEREOF 03-26-2009
164. 20090076077 Methods and Compositions for Selectin Inhibition 03-19-2009
165. 20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof 03-19-2009
166. 20090075283 Vectors and Methods for Cloning Gene Clusters or Portions Thereof 03-19-2009
167. 20090072189 METHOD OF MAKING HEAT CELLS COMPRISING EXOTHERMIC COMPOSITIONS HAVING ABSORBENT GELLING MATERIAL 03-19-2009
168. 20090069564 Methods and Compositions for Selectin Inhibition 03-12-2009
169. 20090069370 AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 03-12-2009
170. 20090069342 KV1.5 POTASSIUM CHANNEL INHIBITORS - 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1 03-12-2009
171. 20090069319 IMIDAZOPYRIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 03-12-2009
172. 20090069300 ISOQUINOLINYL AND ISOINDOLINYL DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 03-12-2009
173. 20090068232 ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS 03-12-2009
174. 20090068231 LIVE ATTENUATED MYCOPLASMA STRAINS - live attenuated Mycoplasma bacteria that exhibit reduced expression of one or more proteins selected from the group 03-12-2009
175. 20090062281 3-QUINOLINECARBONITRILE PROTEIN KINASE INHIBITORS 03-05-2009
176. 20090062131 NUCLEIC ACID ARRAYS FOR DETECTING GENE EXPRESSION IN ANIMAL MODELS OF INFLAMMATORY DISEASES 03-05-2009
177. 20090061423 PHARMACOGENOMIC MARKERS FOR PROGNOSIS OF SOLID TUMORS 03-05-2009
178. 20090061024 COMPOSITIONS AND METHODS EMPLOYING NMDA ANTAGONISTS FOR ACHIEVING AN ANESTHETIC-SPARING EFFECT 03-05-2009
179. 20090060952 PRODUCTION OF THE LIPIDATED FORM OF THE PEPTIDOGLYCAN-ASSOCIATED LIPROPROTEINS OF GRAM-NEGATIVE BACTERIA 03-05-2009
180. 20090054484 SUBSTITUTED HETEROARYL BENZOFURAN ACIDS - generally to substituted heteroaryl benzofuran acids and methods of using them 02-26-2009
181. 20090054392 NAPHTHYLPYRIMIDINE, NAPHTHYLPYRAZINE AND NAPHTHYLPYRIDAZINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 02-26-2009
182. 20090048320 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE 02-19-2009
183. 20090048286 Inhibitors of Protein Tyrosine Phosphatase 1B 02-19-2009
184. 20090048282 PYRIMIDINE SULFONAMIDE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 02-19-2009
185. 20090047287 MODULATION OF BONE FORMATION - This invention relates to modulating Ror activity and/or 14-3-3 02-19-2009
186. 20090042964 AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS 02-12-2009
187. 20090042912 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE 02-12-2009
188. 20090042908 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR BETA-SECRETASE MODULATION 02-12-2009
189. 20090036458 ENDOPARASITICIDAL TOPICAL COMPOSITIONS - composition which comprises: an effective amount of praziquantel and a second endoparasiticidal agent selected 02-05-2009
190. 20090036439 3-ARYL-4-HYDROXYFURANONE COMPOUNDS AND THE HUMAN AND ANIMAL HEALTH USE THEREOF 02-05-2009
191. 20090035807 ANALYSIS OF POLYPEPTIDE PRODUCTION - methods of evaluating a process to produce a polypeptide preparation or evaluating an element of a process to 02-05-2009
192. 20090023925 N'-(2-HALOBENZYLIDENE)SULFONYLHYDRAZIDES AS INTERMEDIATES IN THE MANUFACTURE OF ARYLSULFONYLINDAZOLES 01-22-2009
193. 20090023707 AMINOALKYLAZOLE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 01-22-2009
194. 20090022753 Surface proteins of streptococcus pyogenes 01-22-2009
195. 20090022731 Arthritis-associated B cell gene expression 01-22-2009
196. 20090018332 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors 01-15-2009
197. 20090017067 EMULSION VACCINE COMPOSITIONS COMPRISING ANTIGEN AND ADJUVANT IN THE AQUEOUS PHASE 01-15-2009
198. 20090017064 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus 01-15-2009
199. 20090012308 PROCESS FOR THE MANUFACTURE OF BENZYLSULFONYLARENES 01-08-2009
200. 20090012139 AMINO-5-[4-(DIFLUOROMETHOXY) PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF BETA-SECRETASE 01-08-2009
201. 20090012095 HUMAN N-TYPE CALCIUM CHANNEL BLOCKERS - This invention features a method for modulating human N-type calcium channel 01-08-2009
202. 20090010963 Raccoon Poxvirus Expressing Rabies Glycoproteins 01-08-2009
203. 20080319046 SUBSTITUTED SULFONAMIDE-INDOLES - generally to substituted sulfonamide indoles such as substituted sulfonamide indoles, and methods of using them 12-25-2008
204. 20080319011 PROTEIN TYROSINE KINASE ENZYME INHIBITORS 12-25-2008
205. 20080318971 TREATMENT OF IMATINIB RESISTANT LEUKEMIA 12-25-2008
206. 20080318921 Tricyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors 12-25-2008
207. 20080317776 Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor 12-25-2008
208. 20080312422 PROCESSES FOR MAKING HYDRAZIDES - method is disclosed for preparing hydrazides from hydrazine and an acyl chloride which comprises the steps of 12-18-2008
209. 20080312308 SUBSTITUTED ACETIC ACID DERIVATIVES - generally to substituted acetic acid derivatives and methods of using them 12-18-2008
210. 20080312203 Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors 12-18-2008
211. 20080306138 STABLE NON-AQUEOUS POUR-ON COMPOSITIONS - stable antiparasitic non-aqueous pour-on parasiticidal composition which comprises an effective amount of 12-11-2008
212. 20080306106 1-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 12-11-2008
213. 20080306091 AMINO-5-(5-MEMBERED)HETERO-ARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR beta-SECRETASE MODULATION 12-11-2008
214. 20080299668 DETECTION AND QUANTITATION OF CALICHEAMICIN 12-04-2008
215. 20080299149 Raccoon Poxvirus Expressing Genes of Feline Antigens 12-04-2008
216. 20080299141 Raccoon Poxvirus Expressing Genes of Porcine Virus 12-04-2008
217. 20080293790 SUBSTITUTED ARYL OXIMES - and methods of using them 11-27-2008
218. 20080293771 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS 11-27-2008
219. 20080293722 Ion Channel Modulators - compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions 11-27-2008
220. 20080293712 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof 11-27-2008
221. 20080293688 AMINOAZACYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-27-2008
222. 20080293583 Methods for diagnosing mood disorders - generally to the fields of neuroscience, proteomics and mood disorders 11-27-2008
223. 20080287452 HETEROARYL/ARYL PYRIMIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM 11-20-2008
224. 20080287424 AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORS 11-20-2008
225. 20080280894 DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-13-2008
226. 20080280893 SUBSTITUTED-DIHYDRO[1,4]OXAZINO[2,3,4-hi]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS 11-13-2008
227. 20080280774 Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia 11-13-2008
228. 20080279874 COMPOSITIONS AND METHODS FOR MODULATION OF PLK1 KINASE ACTIVITY 11-13-2008
229. 20080275073 CRYSTALLINE FORMS AND POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS PHARMACEUTICALLY ACCEPTABLE SALTS 11-06-2008
230. 20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster 11-06-2008
231. 20080269213 8-Hydroxyquinoline compounds and methods thereof 10-30-2008
232. 20080262010 CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS D-GLUCORONATE SALTS 10-23-2008
233. 20080262009 CRYSTALLINE POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS ACETATE SALTS 10-23-2008
234. 20080262008 CRYSTALLINE FORMS AND POLYMORPHS OF N-(3-(DIMETHYLAMINO)PROPYL)-4-(4-(3-FLUORO-4-METHOXYPHENYL) PYRIMIDIN-2-YLAMINO) BENZENESULFONAMIDE AS SUCCINATE SALTS 10-23-2008
235. 20080255192 Methods and Compositions for Selectin Inhibition 10-16-2008
236. 20080255157 6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents 10-16-2008
237. 20080254119 Imbedded liquid lubricants for tableting 10-16-2008
238. 20080249148 Synthesis and characterization of polymorph form III 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile 10-09-2008
239. 20080247955 Inflammation treatment, detection and monitoring via TREM-1 10-09-2008
240. 20080242716 Ion Channel Modulators - compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions 10-02-2008
241. 20080242700 Methods and Compositions for Selectin Inhibition 10-02-2008
242. 20080241192 Vaccination against multiple serotypes of pasteurella multocida 10-02-2008
243. 20080241129 ADIPOCYTE SECRETED PROTEIN CCDC80 IS A POTENT STIMULATOR OF BONE FORMATION 10-02-2008
244. 20080234340 Synthesis and characterization of polymorph form II of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-YL)thiazol-4-YL)benzonitrile 09-25-2008
245. 20080234300 Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof 09-25-2008
246. 20080234262 PYRAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS 09-25-2008
247. 20080233127 IMIDAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS PI3 KINASE AND MTOR INHIBITORS 09-25-2008
248. 20080227850 USE OF NOREPINEPHRINE REUPTAKE MODULATORS FOR PREVENTING AND TREATING VASOMOTOR SYMPTOMS 09-18-2008
249. 20080226676 Multivalent avian influenza vaccines and methods 09-18-2008
250. 20080226645 Methods and compositions for assessment and treatment of asthma 09-18-2008
251. 20080221181 COMPOUNDS FOR TREATING TUMORS - The invention provides compounds of formula : wherein E, A, B', R 09-11-2008
252. 20080221057 SECRETED PROTEIN CCDC80 REGULATES ADIPOCYTE DIFFERENTIATION 09-11-2008
253. 20080220094 Compositions and methods for the treatment and/or prevention of osteoporosis 09-11-2008
254. 20080214647 SUBSTITUTED INDOLE ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 09-04-2008
255. 20080213317 AVIAN E. COLI VACCINE FOR PROTECTION AGAINST COLIBACILLOSIS 09-04-2008
256. 20080206281 Method For Producing Storage Stable Viruses and Immunogenic Compositions Thereof 08-28-2008
257. 20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands 08-21-2008
258. 20080199534 Stability in vitamin and mineral supplements 08-21-2008